Interviews - Page 6 of 9

This conversation looks at a startup tackling a precise operational choke point: medication-adherence outreach in U.S. ambulatory care and pharmacy settings. Instead of promising to “fix the EMR,” Rivvi positions itself around the messy, human workflows that sit beside it – call lists, spreadsheets, payer feeds – and uses conversational AI to turn those inputs into structured, attributable actions.

A multi-pathology AI “copilot” that analyzes chest/abdomen CTs. It detects, segments, and packages results for over 20 acute pathologies in parallel targeting emergency department. We asked the founder of xAID, Kirill Lopatin, to walk us through the system’s core workflow.

Theranostics in nuclear medicine is a modern, mainstream approach that unites cancer diagnosis and treatment into a single, integrated system. It not only enables precise identification of tumors and their metastases but also allows targeted radionuclide therapy. Today, these methods are increasingly being included in international treatment protocols and offer patients a real chance to extend their lives and improve quality of life.